Omnipod? for HCPs (Europe)的封面图片
Omnipod? for HCPs (Europe)

Omnipod? for HCPs (Europe)

医疗设备制造业

Our mission is to improve the lives of people living with type 1 diabetes by making it a smaller part of life.

关于我们

This account is intended for a healthcare professional audience in Europe. Omnipod began with a vision from a father and entrepreneur who looked at his young son’s options for insulin delivery and wasn’t satisfied. He knew there had to be a better way. So, he got to work. From Insulet’s first iteration of Pod therapy to today’s revolutionary Omnipod 5 Automated Insulin Delivery System, our customers’ needs remain our inspiration and drive our progress. Omnipod? is a tubeless, waterproof* insulin pump that provides continuous insulin delivery for up to 3 days through a wearable Pod. The simple, connected device offers freedom to people living with type 1 diabetes in Europe. *The Pod has an IP28 rating for up to 25 feet for 60 minutes. The PDM/Controller is not waterproof.

网站
https://www.omnipod.com/en-gb/hcp
所属行业
医疗设备制造业
规模
超过 10,001 人

动态

  • Attention HCPs from Belgium and Switzerland: Omnipod? 5 Automated Insulin Delivery System is set to be available soon for your patients. Join our local informational webinar to learn more about Omnipod 5 and how it works for your patients with T1D. ?? What’s on the agenda? ? Omnipod 5 System Overview ? Omnipod 5 initiation for people living with T1D ?? This will be followed by an interactive Q&A session Join Prof. Régis Coutant & Dr. Sa?d Bekka as they lead this session. ?? Monday, March 24, 2025 ?? 17-18:30 GMT+1 (Brussels time) ?? Online delivered in French Learn more about this exciting new innovation in the management of T1 diabetes. Sign up:?https://lnkd.in/erhkDEaj #Omnipod5 #DiabetesCare #MedicalEducation #Healthcare #SimplifyDiabetes

  • Exciting news from ATTD 2025 in Amsterdam—the Omnipod team is here and ready to connect! This year, we have an action-packed lineup showcasing the Omnipod 5 Automated Insulin Delivery System and its transformative impact on both clinical outcomes and quality of life for people with diabetes. Visit us at booth 28 to learn more, and don’t miss our key events this week: ?? March 19: Our Sponsored Symposium, where expert speakers will dive into how Omnipod 5 enhances user experience and simplifies diabetes management. ??? March 22: Our Oral Presentation unveiling results from the RADIANT trial, comparing glycaemic outcomes of multiple daily injections with a CGM vs. Omnipod 5 with the FreeStyle Libre 2 sensor. ??? Live Podcast Recordings: Catch TypeCast and Within Range recorded live from the show floor! If you're attending ATTD, we’d love to see you—stop by booth 28 and say hello! ? #ATTD2025 #diabetes #Omnipod5

  • Attending ATTD 2025? Don’t miss Insulet’s Oral Presentation on RADIANT RCT! ? On Saturday March 22nd,?Dr. Emma Wilmot will share the results of our groundbreaking RADIANT randomized controlled trial, which compared glycemic outcomes between multiple daily injections (MDI) plus CGM and Omnipod? 5 with the FreeStyle Libre 2 sensor. The oral presentation kicks off at 10:50 in Hall D1. Attendees are also welcome to visit the Omnipod team at booth 28 during the show to get hands on details about the Omnipod 5 Automated Insulin Management System. #ATTD2025 #diabetes #Omnipod5

    • 该图片无替代文字
  • If you're attending ATTD 2025 this week, be sure to join the Insulet Sponsored Symposium, "Transform Your Clinical Care with Omnipod? 5: Revolutionizing Diabetes Management!" Led by Dr. Trang Ly, Insulet’s Senior Vice President and Medical Director, this engaging session will feature a panel of expert speakers discussing the clinical impact of Omnipod? 5. Learn how its innovative design enhances quality of life, delivers an unparalleled user experience, and expands access to the broadest populations through its simplicity. The symposium will also highlight key findings from the groundbreaking RADIANT randomized controlled trial, which compared glycemic outcomes between multiple daily injections (MDI) plus CGM and Omnipod? 5 with the FreeStyle Libre 2 sensor. Don’t miss this opportunity to gain valuable insights into the future of diabetes management Wednesday 19th March at 14:40 CET in Hall E. #ATTD2025 #diabetes #Omnipod5

    • 该图片无替代文字
  • The countdown is on—just 5 more days until ATTD 2025 kicks off in Amsterdam! As the premier event for healthcare professionals dedicated to advancing diabetes care, ATTD is the place to learn more about the Omnipod? 5 Automated Insulin Delivery System and gain strategies for integrating Omnipod 5 into your clinical practice. Visit us at booth 28 to go hands on with Omnipod 5, and get your questions answered by our team. Plus, don’t miss our Insulet Sponsored Symposium, “Transform Your Clinical Care with Omnipod? 5: Revolutionizing Diabetes Management,” happening on Wednesday 19th March at 14:40 CET in Hall E. #ATTD2025 #diabetes #Omnipod5

    • 该图片无替代文字
  • ?? Save the Date: ATTD 2025 - Amsterdam is Almost Here! The latest advancements in diabetes technology. World-renowned speakers. Breakthrough innovations that are shaping the future of diabetes care. The Advanced Technologies & Treatments for Diabetes (ATTD) Congress 2025 is the must-attend event for HCPs looking to stay ahead in diabetes management—and Insulet will be right at the heart of it! ?? Visit Us at Booth 28 ??? Key Session: Insulet Industry Symposium on Wednesday, March 19th, 14:40 – 16:10 (CET) ?? What to Expect: ? Exclusive insights on the future of automated insulin delivery (AID) ? Real-world evidence on Omnipod? 5’s impact on patient outcomes ? Practical tips for integrating Omnipod into your practice Will you be at ATTD? Let us know in the comments! #Omnipod5 #DiabetesCare #Omnipod #HealthcareInnovation #ATTD2025 #SimplifyDiabetes #SimplifyLife #DiabetesTech

    • 该图片无替代文字
  • 查看Omnipod? for HCPs (Europe)的组织主页

    690 位关注者

    Choice in access to effective diabetes management technology is vitally important for people living with T1D, and a CGM is not enough. At Insulet we welcome this recent publication issuing the following call to action: · For all stakeholders in the health ecosystem to fully recognise the value of AID systems · To HCPs to better enable choice in access to AID systems · To healthcare systems to prioritise the provision of AID systems Read the publication in full here: https://lnkd.in/erxGPNE2 #diabetes

  • ?? Save the Date: ATTD 2025 - Amsterdam is Almost Here! The latest advancements in diabetes technology. World-renowned speakers. Breakthrough innovations that are shaping the future of diabetes care. Advanced Technologies & Treatments for Diabetes (ATTD) Congress 2025 is the must-attend event for HCPs looking to stay ahead in diabetes management—and Insulet will be right at the heart of it! ?? Visit Us at Booth 28 ??? Key Session: Insulet Industry Symposium on Wednesday, March 19th, 14:40 – 16:10 (CET) ?? What to Expect: ? Exclusive insights on the future of automated insulin delivery (AID) ? Real-world evidence on Omnipod? 5’s impact on patient outcomes ? Practical tips for integrating Omnipod into your practice Will you be at ATTD? Let us know in the comments! #Omnipod5 #DiabetesCare #Omnipod #HealthcareInnovation #ATTD2025 #SimplifyDiabetes #SimplifyLife #DiabetesTech

    • 该图片无替代文字
  • 查看Omnipod? for HCPs (Europe)的组织主页

    690 位关注者

    Policy, access and uptake: Powering up diabetes tech ? This was what we tackled this week. Ultimately, how can we improve access to insulin delivery technology in type 1 diabetes? Our very first EU policy roundtable, bringing together healthcare professionals, policymakers, and people living with T1D for a discussion that was truly inspiring, full of insights, challenges, and solutions that can drive real change. ?? Key takeaways: ? Choice matters – People with T1D should have access to the insulin delivery technology that works best for them. It's about empowerment, better outcomes, and quality of life. ? Collaboration drives impact – Policymakers, HCPs, and industry must work together to ensure access isn't just an idea, but a reality. What’s next? We’re turning today’s insights into action. This roundtable is just the first step, we will be drafting a white paper to capture these insights and outline concrete policy recommendations. We will post further updates here. A huge thank you to all participants for your contributions chantal mathieu, Ties Obers, Bernhard Gehr, Wanda Lutogniewska, Nicholas Tentolouris, and MEP Vytenis Andriukaitis. We look forward to driving real impact together. #diabetes

    • 该图片无替代文字

关联主页

相似主页